Jacob Lennert Veerman (Lennert Veerman, J Lennert Veerman)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Venues

Griffith University

Erasmus Universiteit Rotterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Griffith University Jan 09 2018

Australia

Professor of Public Health :: School of Medicine

Cancer Council NSW Feb 01 2017 - Dec 31 2017

Australia

Senior Health Economist :: Cancer Research Division

University of Queensland Jan 01 2017 - Apr 01 2017

Australia

Senior Research Fellow (P/T) :: School of Public Health

The University of Queensland - Dec 23 2016

Australia

Senior Lecturer & MPH Program Director :: School of Public Health

The University of Queensland

Australia

Senior Research Fellow :: School of Population Health

The University of Queensland

Australia

Research Fellow :: School of Population Health

Erasmus MC

Netherlands

Researcher :: Department of Public Health

Medical Care Asylum Seekers NL

Netherlands

Public Health Physician

Education History

Erasmus Universiteit Rotterdam

Netherlands

PHD :: Department of Public Health

Nihes - Netherlands Institute for Health Sciences

Netherlands

MSC

VU University Amsterdam

Netherlands

PHD

Publications

Deborah J Schofield, Katherine Lim, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan Passey, Rupendra Shrestha
Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data. BMJ open 14 (5) (2024)
Matti Marklund, Leopold Ndemnge Aminde, Mary Njeri Wanjau, Boni M Ale, Adedayo E Ojo, Clementina E Okoro, Abimbola Adegboye, Liping Huang, Jacob Lennert Veerman, Jason Hy Wu, Mark D Huffman, Dike B Ojji
Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria: cost-effectiveness analysis. BMJ global health 9 (4) (2024)
Deborah J Schofield, Katherine Lim, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan Passey, Rupendra Shrestha
Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data. BMJ open 14 (5) (2024)
Deborah J Schofield, Katherine Lim, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan Passey, Rupendra Shrestha
Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data. BMJ open 14 (5) (2024)
Matti Marklund, Leopold Ndemnge Aminde, Mary Njeri Wanjau, Boni M Ale, Adedayo E Ojo, Clementina E Okoro, Abimbola Adegboye, Liping Huang, Jacob Lennert Veerman, Jason Hy Wu, Mark D Huffman, Dike B Ojji
Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria: cost-effectiveness analysis. BMJ global health 9 (4) (2024)
Matti Marklund, Leopold Ndemnge Aminde, Mary Njeri Wanjau, Boni M Ale, Adedayo E Ojo, Clementina E Okoro, Abimbola Adegboye, Liping Huang, Jacob Lennert Veerman, Jason Hy Wu, Mark D Huffman, Dike B Ojji
Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria: cost-effectiveness analysis. BMJ global health 9 (4) (2024)
Matti Marklund, Leopold Ndemnge Aminde, Mary Njeri Wanjau, Boni M Ale, Adedayo E Ojo, Clementina E Okoro, Abimbola Adegboye, Liping Huang, Jacob Lennert Veerman, Jason Hy Wu, Mark D Huffman, Dike B Ojji
Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria: cost-effectiveness analysis. BMJ global health 9 (4) (2024)
Matti Marklund, Leopold Ndemnge Aminde, Mary Njeri Wanjau, Boni M Ale, Adedayo E Ojo, Clementina E Okoro, Abimbola Adegboye, Liping Huang, Jacob Lennert Veerman, Jason Hy Wu, Mark D Huffman, Dike B Ojji
Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria: cost-effectiveness analysis. BMJ global health 9 (4) (2024)
Matti Marklund, Leopold N Aminde, Mary Njeri Wanjau, Liping Huang, Celine Awuor, Lindsay Steele, Laura K Cobb, Jacob Lennert Veerman, Jason Hy Wu
Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis. BMJ global health 8 (10) (2023)
Mary Njeri Wanjau, Holger Möller, Fiona Anne Haigh, Andrew Milat, Rema Hayek, Peta Lucas, Jacob Lennert Veerman
The Potential Impact of Physical Activity on the Burden of Osteoarthritis and Low Back Pain in Australia: A Systematic Review of Reviews and Life Table Analysis. Journal of physical activity & health (2023)
Leopold Ndemnge Aminde, Mary Njeri Wanjau, Linda J Cobiac, Jacob Lennert Veerman
Estimated Impact of Achieving the Australian National Sodium Reduction Targets on Blood Pressure, Chronic Kidney Disease Burden and Healthcare Costs: A Modelling Study. Nutrients 15 (2) (2023)
Leopold Ndemnge Aminde, Mary Njeri Wanjau, Linda J Cobiac, Jacob Lennert Veerman
Estimated Impact of Achieving the Australian National Sodium Reduction Targets on Blood Pressure, Chronic Kidney Disease Burden and Healthcare Costs: A Modelling Study. Nutrients 15 (2) (2023)
Leopold Ndemnge Aminde, Mary Njeri Wanjau, Linda J Cobiac, Jacob Lennert Veerman
Estimated Impact of Achieving the Australian National Sodium Reduction Targets on Blood Pressure, Chronic Kidney Disease Burden and Healthcare Costs: A Modelling Study. Nutrients 15 (2) (2023)
Leopold Ndemnge Aminde, Mary Njeri Wanjau, Linda J Cobiac, Jacob Lennert Veerman
Estimated Impact of Achieving the Australian National Sodium Reduction Targets on Blood Pressure, Chronic Kidney Disease Burden and Healthcare Costs: A Modelling Study. Nutrients 15 (2) (2023)
Mary Njeri Wanjau, Lucy W Kivuti-Bitok, Leopold Ndemnge Aminde, Jacob Lennert Veerman
The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study. Cost effectiveness and resource allocation : C/E 21 (1) (2023)
Deborah Schofield, Melanie J B Zeppel, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan E Passey, Rupendra N Shrestha
Individual and national financial impacts of informal caring for people with mental illness in Australia, projected to 2030. BJPsych open 8 (4) (2022)
Deborah Schofield, Melanie J B Zeppel, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan E Passey, Rupendra N Shrestha
Intellectual disability and autism: socioeconomic impacts of informal caring, projected to 2030. The British journal of psychiatry : the journal of mental science 215 (5) (2021)
Mary Njeri Wanjau, Lucy W Kivuti-Bitok, Leopold Ndemnge Aminde, Jacob Lennert Veerman
Stakeholder perceptions of current practices and challenges in priority setting for non-communicable disease control in Kenya: a qualitative study. BMJ open 11 (4) (2021)
Matti Marklund, Miaobing Zheng, Jacob Lennert Veerman, Jason H Y Wu
Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study. PLoS medicine 17 (11) (2020)
Leopold Ndemnge Aminde, Linda J Cobiac, Jacob Lennert Veerman
Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study. BMJ open 10 (11) (2020)
Jaithri Ananthapavan, Gary Sacks, Vicki Brown, Marj Moodie, Phuong Nguyen, Jacob Lennert Veerman, Ana Maria Mantilla Herrera, Anita Lal, Anna Peeters, Rob Carter
Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study. PloS one 15 (6) (2020)
David E Goldsbury, Marianne F Weber, Sarsha Yap, Nicole M Rankin, Preston Ngo, Jacob Lennert Veerman, Emily Banks, Karen Canfell, Dianne L O'Connell
Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study. PloS one 15 (8) (2020)
Deborah Schofield, Michelle Cunich, Rupendra Shrestha, Robert Tanton, Jacob Lennert Veerman, Simon Kelly, Megan Passey
Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030. BJPsych open 5 (3) (2019)
Mary Njeri Wanjau, Belen Zapata-Diomedi, Jacob Lennert Veerman
Health promotion at the workplace setting: a protocol for a systematic review of effectiveness and sustainability of current practice in low-income and middle-income countries. BMJ open 9 (5) (2019)
Hannah Elizabeth Carter, Deborah J Schofield, Rupendra Shrestha, Jacob Lennert Veerman
The productivity gains associated with a junk food tax and their impact on cost-effectiveness. PloS one 14 (7) (2019)
Deborah Schofield, Rupendra N Shrestha, Melanie J B Zeppel, Michelle M Cunich, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan E Passey
Economic costs of informal care for people with chronic diseases in the community: Lost income, extra welfare payments, and reduced taxes in Australia in 2015-2030. Health & social care in the community 27 (2) (2018)
Emily Jane Bourke, Jacob Lennert Veerman
The potential impact of taxing sugar drinks on health inequality in Indonesia. BMJ global health 3 (6) (2018)
David E Goldsbury, Sarsha Yap, Marianne F Weber, Jacob Lennert Veerman, Nicole Rankin, Emily Banks, Karen Canfell, Dianne L O'Connell
Health services costs for cancer care in Australia: Estimates from the 45 and Up Study. PloS one 13 (7) (2018)
Shauna M Downs, Milan Z Bloem, Miaobing Zheng, Elise Catterall, Beth Thomas, Jacob Lennert Veerman, Jason Hy Wu
The Impact of Policies to Reduce trans Fat Consumption: A Systematic Review of the Evidence. Current developments in nutrition 1 (12) (2017)

Jacob Lennert Veerman.css-eqlu8i{font-size:small;padding-left:4px;} (Lennert Veerman, J Lennert Veerman)

Publication Activity (10 Years)

Top Topics

Top Venues

Jacob Lennert Veerman (Lennert Veerman, J Lennert Veerman)